Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 10, 2026 08:23 ET | Source: Research and Markets

Esperoct (Novo Nordisk) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, & Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, March 10, 2026 (GLOBE NEWSWIRE) -- The "Esperoct Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
March 10, 2026 05:21 ET | Source: Research and Markets

Rebyota (Ferring Pharmaceuticals) Market Research Report 2026: Epidemiology, Competitive Landscape, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, March 10, 2026 (GLOBE NEWSWIRE) -- The "Rebyota Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
March 09, 2026 12:19 ET | Source: Research and Markets

Ixiaro (Valneva) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, March 09, 2026 (GLOBE NEWSWIRE) -- The "Ixiaro Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
March 09, 2026 12:10 ET | Source: Research and Markets

Jetrea (Oxurion) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, March 09, 2026 (GLOBE NEWSWIRE) -- The "Jetrea Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
February 24, 2026 08:30 ET | Source: Shorepower Technologies Inc.

Shorepower Technologies (OTC: SPEV) Enters Merger Agreement with Aeternum Health LLC and Announces Strategic Transition to Longevity-Focused Healthcare Platform

Shorepower Technologies (OTC: SPEV) Enters Merger Agreement with Aeternum Health LLC
February 18, 2026 11:13 ET | Source: Research and Markets

Bionic Devices Market Competitor Analysis Report 2025: Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts to 2033

Dublin, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The "Competitor Analysis of Bionic Devices Market Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and...
January 29, 2026 10:23 ET | Source: Research and Markets

Cell Therapy Collaboration and Licensing Agreements Trends Report 2025 with Directory of 989 Deals - Upfront, Milestone, Royalties, Company A-Z, Deal Type and Therapy Area

Dublin, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The "Cell Therapy Collaboration and Licensing Deals 2016-2025" report has been added to ResearchAndMarkets.com's offering. This report contains a...
January 29, 2026 06:00 ET | Source: OMEICOS Therapeutics GmbH

OMEICOS Therapeutics Announces Positive Phase 2 Study Outcome Demonstrating OMT-28’s Potential in Primary Mitochondrial Diseases (PMD)

OMEICOS Therapeutics Announces Positive Phase 2 Study Outcome Demonstrating OMT-28’s Potential in Primary Mitochondrial Diseases (PMD)
January 28, 2026 10:30 ET | Source: Steadman Philippon Research Institute

Steadman Philippon Research Institute and Vail Health Renew Landmark Partnership with 5-Year Commitment

Vail, Colorado, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Steadman Philippon Research Institute (SPRI) and Vail Health have renewed their longstanding partnership with a new five-year agreement advancing...
January 21, 2026 09:30 ET | Source: John Snow Labs

Redefining Real-World Evidence: John Snow Labs Introduces First FDA-Ready Patient Journey Platform

Designed for secondary use of multimodal, longitudinal patient data, PJI embeds regulatory-grade governance and transparency into every patient journey.